Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant

• Status: Unknown status
• Trial end date: 2012-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to examine if outcome after liver transplantation is improved by using albumin infusion post-transplantation.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: McGill University Health Center; McGill University Health Centre/Research Institute of the McGill University Health Centre

Criteria

Inclusion Criteria:

• 18 years or older

• Canadian Transplant status 1 or 2

• Patients at the Royal Victoria Hospital, Montreal, Canada

Exclusion Criteria:

• Emergency liver transplant (canadian transplant status 3 or 4)

• patients who have received more than 300cc of albumin within 48 hours prior to transplant

• patients who underwent previous solid organ transplant

• multi-organs transplant recipients

• patients who had previous adverse reaction to human albumin solution

• patients who have religious restriction to receiving human blood products.

• patients or surrogate unable to give consent to the study